{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:02Z","timestamp":1780426862460,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>In recent years, 2 molecular types have been defined in urothelial carcinoma, as luminal and basal. The molecular subtyping is generally based on genetic studies in non-muscle invasive bladder cancer (NMIBC) however the studies with immunohistochemical reflection of this subtyping in NMIBC is limited. In our study, we aimed to use GATA3 and keratin 5\/6 for subtyping of NMIBC, and to investigate the follow-up results. Materials and methods: Patients who underwent transurethral resection for the first time and whose final diagnosis was reported as NMIBC were prospectively included. A block representing the tumor was stained with GATA3 and keratin 5\/6.The relationships between the subtypes and demographic data, recurrence rates, and time to recurrence were evaluated. A total of 100 patients diagnosed with NMIBC were included. The keratin 5\/6 negativity was 64% and all of these patients were GATA3 positive. The keratin 5\/6 positivity was 36%. None of the age, tumor size, lamina propria invasion, keratin 5\/6 and GATA3 positivity were significant for predicting the risk of recurrence. The mean time to recurrence was 283 days and 332 days in the keratin 5\/6 positive and negative group, respectively but the relation was not statistically significant. Molecular classification is difficult due to technical reasons, but it can be performed with GATA3 and keratin 5\/6 by immunohistochemistry. New studies are needed to determine the clinical differences and to specialize the management of bladder tumors.<\/jats:p>","DOI":"10.1097\/md.0000000000044808","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:00:28Z","timestamp":1759248028000},"page":"e44808","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic difference of molecular subtypes in non-muscle invasive bladder cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Mahmut Naci","family":"\u00c7atal","sequence":"first","affiliation":[{"name":"Department of Urology, Mu\u011fla Sitki Ko\u00e7man University Faculty of Medicine, Mu\u011fla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lker","family":"Akarken","sequence":"additional","affiliation":[{"name":"Department of Urology, Mu\u011fla Sitki Ko\u00e7man University Faculty of Medicine, Mu\u011fla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-2236","authenticated-orcid":false,"given":"Yelda","family":"Dere","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mu\u011fla Sitki Ko\u00e7man University Faculty of Medicine, Mu\u011fla, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Delikta\u015f","sequence":"additional","affiliation":[{"name":"Department of Urology, Mu\u011fla Sitki Ko\u00e7man University Faculty of Medicine, Mu\u011fla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Tarhan","sequence":"additional","affiliation":[{"name":"Department of Urology, Mu\u011fla Sitki Ko\u00e7man University Faculty of Medicine, Mu\u011fla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Urology, Mu\u011fla Sitki Ko\u00e7man University Faculty of Medicine, Mu\u011fla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1100\/2011\/412739","article-title":"Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance.","volume":"11","author":"Patel","year":"2011","journal-title":"ScientificWorldJ"},{"key":"R2-20260602","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0094-0143(21)00412-2","article-title":"Cytologic and histologic features of superficial bladder cancer.","volume":"19","author":"Ro","year":"1992","journal-title":"Urol Clin North Am"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladdercancer: epidemiology, staging and grading, and diagnosis.","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/IJPM.IJPM_228_18","article-title":"Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.","volume":"62","author":"Agarwal","year":"2019","journal-title":"Indian J Pathol Microbiol"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"4920236","DOI":"10.1155\/2020\/4920236","article-title":"CK20 and CK5\/6 immunohistochemical staining of urothelial neoplasms: a perspective.","volume":"2020","author":"Akhtar","year":"2020","journal-title":"Adv Urol"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1038\/s41598-020-66747-7","article-title":"Assessment of luminal and basal phenotypes in bladder cancer.","volume":"10","author":"Guo","year":"2020","journal-title":"Sci Rep"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use.","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMedicine"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.5230","article-title":"Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts.","volume":"247","author":"Sj\u00f6dahl","year":"2019","journal-title":"J Pathol"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-17-2719","article-title":"Molecular markers increase precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.","volume":"24","author":"van Kessel","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Commentary on: \u201ccomprehensive transcriptional analysis of early-stage urothelial carcinoma.\u201d","volume":"30","author":"Lee","year":"2016","journal-title":"Cancer Cell"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.3390\/ijms21207726","article-title":"Non-muscle-invasive bladder carcinoma with respect to basal versus luminal keratin expression.","volume":"21","author":"Jung","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5301\/uro.5000072","article-title":"Analysis of results of recurrence and progression rates of high-grade Ta bladder cancer and comparison with results of high-grade T1.","volume":"81","author":"Kilinc","year":"2014","journal-title":"Urologia"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer.","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2015.02.021","article-title":"A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma.","volume":"68","author":"Patschan","year":"2015","journal-title":"Eur Urol"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks.","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur Urol"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.molonc.2015.10.021","article-title":"Genome-wide DNA methylation analyses in lung adenocarcinomas: association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.","volume":"10","author":"Bjaan\u00e6s","year":"2016","journal-title":"Mol Oncol"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.urolonc.2018.09.017","article-title":"Molecular footprints of muscle-invasive bladder cancer in smoking and nonsmoking patients.","volume":"37","author":"Fantini","year":"2019","journal-title":"Urol Oncol"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13193-019-01026-0","article-title":"GATA-3 expression in all grades and different variants of primary and metastatic urothelial carcinoma.","volume":"12","author":"Naik","year":"2021","journal-title":"Indian J Surg Oncol"},{"key":"R20-20260602","first-page":"700","article-title":"Cytokeratin 5\/6 expression in pT1 bladder cancer predicts intravesical recurrence in patients treated with bacillus Calmette\u2013Gu\u00e9rin instillation.","volume":"54","author":"Yamamoto","year":"2022","journal-title":"Pathology (Phila)"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-018-3319-4","article-title":"Cytokeratin 5\/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.","volume":"11","author":"Hashmi","year":"2018","journal-title":"BMC Res Notes"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/his.13696","article-title":"Basal\u2010subtype bladder tumours show a \u2018hot\u2019immunophenotype.","volume":"73","author":"Hodgson","year":"2018","journal-title":"Histopathology"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc Natl Acad Sci ABD"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:37Z","timestamp":1780423297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":24,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044808","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}